Home > Latha Jishnu
Turning back the pages
11 April 2023 1:17 PM GMTThe 2013 landmark Supreme Court judgement of 'Novartis v Union of India' offers critical lessons on the intent behind crucial aspects of India’s key...
Spurious endeavour
6 April 2023 1:09 PM GMTThe move to foist a GI tag on Mandu’s baobab tree is part of a drive to push up the GI tally which does not benefit local communities
Trade lessons from 'Cuetlaxochitl'
24 Dec 2022 3:19 PM GMTThe story of poinsettia, a flower with showy-red bracts used for Christmas decorations in America since the 16th century, is a classic example of...
Where do we stand?
13 Oct 2022 10:33 AM GMTPolicy blocks and poor vision have held up 5G in India, while China’s breakthroughs are helping to set global standards
A lethal lapse
29 Sep 2022 3:58 PM GMTCancer and tuberculosis patients have been urging a reluctant government to use compulsory licences to make life-saving drugs accessible
Battle for prestige
15 Sep 2022 2:15 PM GMTModerna is trying to be gatekeeper for the mRNA platform for future drug development — raising monopolistic fears
Repeat of a failure?
25 Aug 2022 6:00 PM GMTA pattern familiar to Covid-19 is emerging in the battle against monkeypox, with the US and Europe grabbing scarce vaccine supplies
Done with vaccines?
28 July 2022 3:13 PM GMTIndia claims vaccines are no longer an issue in the battle against COVID-19, but a host of developing nations would disagree
A tool of war?
27 July 2022 1:54 PM GMTPost the Ukraine war, Russia has held back from appropriating intellectual property despite having a law to punish unfriendly countries
Charity after profiteering!
18 Jun 2022 7:17 PM GMTAfter facing a worldwide censure for earning disproportionately during the pandemic, pharma giant Pfizer has decided to supply its patented,...
Fading momentum?
10 May 2022 1:27 PM GMTIndian and South African interests have diverged; India is not in desperate need of vaccines anymore and doesn’t want to rock the boat
A daring demand
6 May 2022 2:57 PM GMTHealth advocates are asking Washington to use laws that allow patent override on drugs developed with public funds